IP Verse

Vial competitive analysis

Explore patent oppositions filed by Vial against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026

Patent Number	Title	Applicant	Opposition Date
EP4364724	High Concentration Vegf Receptor Fusion Protein Containing Formulations	REGENERON PHARMACEUTICALS	Aug 26, 2026
EP4185318	Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders	BAYER HEALTHCARE	Jun 3, 2026
EP3730126	Liquid Composition Comprising Vegf Antagonist	SAMSUNG BIOEPIS	Feb 13, 2026
EP3241561	Chimeric Antigen Receptor (Car) With Antigen Binding Domains To The T Cell Receptor Beta Constant Region	AUTOLUS	Jan 30, 2026
EP3906220	New Formulation For A Low-Carbon Construction Binder, Method Of Production, And Construction Materials	MATERRUP	Jun 7, 2023
EP3199033	Natural High-Potency Sweetener Compositions With Improved Temporal Profile And/Or Flavor Profile, Methods For Their Formulation, And Uses	THE COCA COLA	Jul 7, 2021
EP3074207	Method For Printing Three-Dimensional Parts Wtih Crystallization Kinetics Control	STRATASYS	Jan 10, 2020
EP2792714	Molded Article	MITSUBISHI GAS CHEMICAL	May 23, 2018
EP2332484	Software Center And Highly Configurable Robotic Systems For Surgery And Other Uses	INTUITIVE SURGICAL OPERATIONS	Oct 24, 2017
EP2213034	Improved Ack/Nack Dtx Detection And Signalling Of Not Receiving A Downlink Allocation Grant Message	NOKIA SIEMENS NETWORKS	May 26, 2015

Discover the latest PTAB cases involving Vial, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Vial with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
VIAL	2	-	-	-
MITSUBISHI GAS CHEMICAL	-	4	-	-
STRATASYS	1	11	-	12